Medtech InsightEconomic growth has slowed in China, volume-based pricing (VBP) is affecting overseas companies’ abilities to compete on a level playing and systemic state support at high levels is offered to the loc
In VivoEconomic growth has slowed in China, volume-based pricing (VBP) is affecting overseas companies’ abilities to compete on a level playing and systemic state support at high levels is offered to the loc
Medtech InsightSome 181 certificates have so far been issued under the EU Medical Device Regulation. “That is the work of 12 months,” said BVMed chairman Meinrad Lugan, addressing a press gathering one week from the
Medtech InsightThe latest Medtech Insight sales ranking of the top 100 publicly-traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting perio